These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7629728)

  • 21. Gelastatins A and B, new inhibitors of gelatinase A from Westerdykella multispora F50733.
    Lee HJ; Chung MC; Lee CH; Yun BS; Chun HK; Kho YH
    J Antibiot (Tokyo); 1997 Apr; 50(4):357-9. PubMed ID: 9186564
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides.
    Xia T; Akers K; Eisen AZ; Seltzer JL
    Biochim Biophys Acta; 1996 Apr; 1293(2):259-66. PubMed ID: 8620038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.
    Shi L; Wang Q; Wang H; Zhou H; Li Y; Li X
    Bioorg Med Chem; 2013 Dec; 21(24):7752-62. PubMed ID: 24247003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2.
    Schwartz JD; Monea S; Marcus SG; Patel S; Eng K; Galloway AC; Mignatti P; Shamamian P
    J Surg Res; 1998 Apr; 76(1):79-85. PubMed ID: 9695744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of gelatinase B/matrix metalloproteinase-9 activity comparison of a peptidomimetic and polyhistidine with single-chain derivatives of a neutralizing monoclonal antibody.
    Hu J; Van den Steen PE; Houde M; Ilenchuk TT; Opdenakker G
    Biochem Pharmacol; 2004 Mar; 67(5):1001-9. PubMed ID: 15104254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An analysis of the conformational changes that accompany the activation and inhibition of gelatinase A.
    Crabbe T; Kelly SM; Price NC
    FEBS Lett; 1996 Feb; 380(1-2):53-7. PubMed ID: 8603746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R; Toth M; Peña D; Mobashery S
    Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic analysis of the mechanism of interaction of full-length TIMP-2 and gelatinase A: evidence for the existence of a low-affinity intermediate.
    Hutton M; Willenbrock F; Brocklehurst K; Murphy G
    Biochemistry; 1998 Jul; 37(28):10094-8. PubMed ID: 9665714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
    Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
    Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell gelatinases mediate basement membrane transmigration in vitro.
    Leppert D; Waubant E; Galardy R; Bunnett NW; Hauser SL
    J Immunol; 1995 May; 154(9):4379-89. PubMed ID: 7722295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms.
    Oliver GW; Leferson JD; Stetler-Stevenson WG; Kleiner DE
    Anal Biochem; 1997 Jan; 244(1):161-6. PubMed ID: 9025922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
    Teesalu T; Masson R; Basset P; Blasi F; Talarico D
    Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.
    Ochieng J; Fridman R; Nangia-Makker P; Kleiner DE; Liotta LA; Stetler-Stevenson WG; Raz A
    Biochemistry; 1994 Nov; 33(47):14109-14. PubMed ID: 7947821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of matrix metalloproteinases by peptidyl hydroxamic acids.
    Odake S; Morita Y; Morikawa T; Yoshida N; Hori H; Nagai Y
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1442-6. PubMed ID: 8147888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.
    Chapman KT; Kopka IE; Durette PL; Esser CK; Lanza TJ; Izquierdo-Martin M; Niedzwiecki L; Chang B; Harrison RK; Kuo DW
    J Med Chem; 1993 Dec; 36(26):4293-301. PubMed ID: 8277511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of a d-pro-lys peptidomimetic inhibitor of MMP9: Addressing the gelatinase selectivity beyond S1' subsite.
    Lenci E; Contini A; Trabocchi A
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127467. PubMed ID: 32768649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of N-carboxyalkyl peptides to the inhibition and affinity purification of the porcine matrix metalloproteinases collagenase, gelatinase, and stromelysin.
    Stack MS; Emberts CG; Gray RD
    Arch Biochem Biophys; 1991 Jun; 287(2):240-9. PubMed ID: 1654808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism.
    Gilbertson-Beadling S; Powers EA; Stamp-Cole M; Scott PS; Wallace TL; Copeland J; Petzold G; Mitchell M; Ledbetter S; Poorman R
    Cancer Chemother Pharmacol; 1995; 36(5):418-24. PubMed ID: 7543375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro.
    Zervos EE; Shafii AE; Haq M; Rosemurgy AS
    J Surg Res; 1999 Jun; 84(2):162-7. PubMed ID: 10357914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide.
    Liu Q; Pan D; Cheng C; Zhang A; Ma C; Wang L; Zhang D; Liu H; Jiang H; Wang T; Xu Y; Yang R; Chen F; Yang M; Zuo C
    Nucl Med Biol; 2015 Dec; 42(12):939-44. PubMed ID: 26344861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.